Abstract: The present invention relates to methods and kits for treating, reducing, or preventing autoimmune conditions such as rheumatoid arthritis by administering to a mammal in need thereof an agent that modulates the expression level or biological activity of Toll-like receptor-9 (TLR-9). Also disclosed are screening methods that make use of TLR-9 for the identification of novel therapeutics for autoimmune conditions.
Type:
Grant
Filed:
January 24, 2005
Date of Patent:
July 5, 2011
Assignee:
Joslin Diebetes Center
Inventors:
Diane Mathis, Christophe O. Benoist, Hsin-Jung Wu